U.S. Transportation Stock News

Glass House Brands recently uplisted to the New York Stock Exchange under the ticker GLAS after restructuring its operations around medical cannabis and moving its adult-use businesses into a wholly owned subsidiary. This shift, coming after federal rescheduling of medical cannabis to Schedule III, reshapes Glass House’s business profile and potential market access, including future interstate and European opportunities. Next, we’ll examine how Glass House’s NYSE uplisting and medical focus...

Earlier this week, Donaldson Company reported fiscal 2026 third-quarter results with adjusted earnings and revenue exceeding analyst estimates and rising from a year ago, while guiding for full-year adjusted EPS of $3.94–$4.01 and organic sales growth of 3–5% across its segments. A key takeaway for investors is the especially strong outlook for the higher-growth Life Sciences segment, where management is targeting 9–11% sales growth, potentially shifting the company’s overall business mix...

The live service model that once helped power hits like Destiny 2 is now under pressure, and that shift is rippling through gaming stocks. As Bungie, owned by Sony, pulls back on Destiny 2 updates and the industry leans toward blockbuster single player titles, investors are reassessing where future cash flows might come from. This article explains how that news connects to three stocks exposed to the same forces, highlighting one where the changing model could be a relative positive and two...

Mortgage lender stocks are in the spotlight again as markets react to a higher 27% implied chance of a Federal Reserve rate hike in July and fresh volatility in mortgage rates. For investors, the key question is which companies might benefit if borrowers rush to lock in current rates and near term mortgage demand pulls forward, and which could feel pressure from higher funding and credit costs. This article explains how that rate backdrop connects to mortgage lenders and highlights 3 stocks...

Acuity Inc. (NYSE: AYI) recently reported its fiscal 2026 third-quarter results, showing year-over-year growth in sales, net income, and earnings per share, while maintaining its dividend and actively repurchasing shares under a long-running buyback program. Management also emphasized a disciplined approach to acquisitions to build out the Acuity Intelligence Spaces portfolio, prioritizing quality assets and balancing growth investments with continued shareholder returns. Now, we’ll explore...

Agilent Technologies (NYSE:A) has released an AI powered xCELLigence RTCA eSight AI software module for biopharma research. The upgrade is designed to automate and standardize cell imaging analysis workflows, which may help reduce manual steps and variability for researchers. The launch introduces AI driven experimental analysis tools that support high throughput drug discovery and related applications. Agilent Technologies enters this launch with its stock at $130.69 and a mixed recent...

Some of the losses seen by insiders who purchased US$372.5k worth of Rapid7, Inc. ( NASDAQ:RPD ) shares over the past...

We'd be surprised if C3.ai, Inc. ( NYSE:AI ) shareholders haven't noticed that the President, Stephen Ehikian, recently...

O'Reilly Automotive (NasdaqGS:ORLY) has reportedly made a cash offer to acquire Genuine Parts Company's auto parts division. The proposed deal is estimated at US$10b or more and would be O'Reilly's largest acquisition since 2008. Genuine Parts is weighing options that may include a spinoff or a sale to O'Reilly or another bidder. O'Reilly Automotive is a major US auto parts retailer serving both professional repair shops and do it yourself customers. The auto parts sector has been shaped by...

ADMA Biologics stock has delivered a very large 5 year gain, yet the broader valuation checks currently lean cheap, setting up a clear tension between past returns and what the market is asking investors to pay today. Over the past 5 years, ADMA Biologics has returned almost 7x, which puts extra focus on whether the current price still reflects a reasonable entry point after such a strong run. Potential margin expansion and progress on its hyperimmune globulin candidate for pneumococcal...

Heightened political tension around President Trump’s July 4 speech, visible partisan branding at the Freedom 250 events, and tighter security on the streets are all feeding into a broader debate about where risk, and potential opportunity, now sit in the market. Defense and security stocks are squarely in that conversation, as government priorities, protest activity, and even extreme weather can all shape budgets and sentiment. This article walks through 3 stocks from our Defense and...

Carlisle Companies has submitted multiple unsolicited acquisition proposals to Owens Corning (NYSE:OC). The approaches signal external interest in acquiring control of Owens Corning and combining the businesses. The proposals introduce the possibility of a change in ownership structure and future direction for Owens Corning. Owens Corning operates as a building products company, with exposure to insulation, roofing, and related materials that are tied to construction and renovation...

Chagee Holdings stock has seen a steep share price decline over the past year, yet its valuation checks currently lean cheap, which sets up a clear tension between weak recent returns and what the broader metrics suggest about value. Over the last 1 year, Chagee Holdings is down 57.1%, which means anyone holding through that period has experienced a substantial drawdown. Future revenue and cash flow execution may support rebuilding confidence in the business, while any pressure on margins or...

AvePoint (AVPT) was added to the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index on 27 June 2026, an inclusion that can draw fresh attention from index-linked funds and institutional investors. See our latest analysis for AvePoint. AvePoint’s recent index inclusions come after a mixed share price record, with a 90 day share price return of 14.26% alongside a year to date share price decline of 13.31%, while the three year total shareholder return of 105.01% points to...

Short term Treasury yields above 4% and banks lifting deposit rates are putting cash and ultra short fixed income back in the spotlight. For investors weighing how to respond to higher yields and shifting expectations for Federal Reserve policy, a key question is which stocks are most exposed to these moves in short duration markets. This article looks at three stocks from a Short Term Fixed Income Opportunities screener that appear positively tied to this rate backdrop, helping you consider...

Fluor stock has delivered a very strong 187.3% return over the past 5 years, and the current valuation checks and recent share price pullback raise a question about how much upside may still be priced in. Over 5 years, Fluor has returned 187.3%, which puts recent short term weakness into the context of a long period of strong gains. Recent progress on large infrastructure and energy projects can support confidence in future cash generation, while execution risk on complex contracts and large...

Tariff headlines can make it hard to judge which U.S. stocks might quietly benefit or face added friction. With Trump’s levies generating record government revenue while much of U.S. trade still enters duty free, the picture for consumer staples is more nuanced than it first appears. This article focuses on three large U.S. consumer staples stocks exposed to the latest tariff backdrop and explains how their essential goods focus, supply chains, and pricing power could shape the way they...

Capricor Therapeutics has delivered a very large 3 year gain, yet the stock now screens as overvalued on market multiples and earns a mixed valuation score, so the recent pullback raises questions about how much of the story is already reflected in the price. Capricor Therapeutics has returned about 4.4x over the past 3 years, which puts extra focus on whether the current share price leaves enough room for disappointment. The upcoming FDA review and PDUFA decision for Deramiocel can be a key...

Air Products and Chemicals stock has delivered a 25.4% gain year to date, and the latest valuation work suggests that this strong run now sits at a premium to the intrinsic value estimate using a Discounted Cash Flow (DCF) approach as well as to market based multiples. Year to date, the share price return of 25.4% points to renewed optimism that may already be reflected in what investors are willing to pay for Air Products and Chemicals. The decision to exit certain clean energy projects...

US regional banks are back in focus as investors assess what Kevin Warsh’s first Federal Reserve meeting minutes might signal for future interest rates. Regional lenders with solid health and risk profiles can be particularly sensitive to changes in the spread between what they earn on loans and pay on deposits. This article looks at how that potential policy direction, and the stronger US dollar that has followed expectations of higher rates, could affect certain regional bank stocks. Ahead,...

Martin Marietta Materials (NYSE:MLM) has agreed to a definitive merger with Lhoist North America valued at about $13.5b. The transaction will combine Martin Marietta Materials' aggregates and heavy building materials operations with Lhoist's North American lime and limestone business. The deal represents an expansion of Martin Marietta Materials' presence in the broader construction materials and industrial minerals space. Martin Marietta Materials operates in aggregates and heavy building...

Hormel Foods (NYSE:HRL) has completed the sale of its whole-bird turkey business. The company has also exited Brazil through the sale of its Ceratti-branded operations. These moves are part of a broader effort to simplify the portfolio and focus on value-added protein markets. Hormel Foods is reshaping its business around higher-value protein categories while stepping away from more commodity-like operations. The stock closed at $25.0, with the share price down 5.7% over the past week and...

Klaviyo stock has fallen 50.2% over the past year, yet recent valuation work suggests the shares may now be trading at a discount to what the company’s cash flows imply through a Discounted Cash Flow (DCF) and market multiples that both point to undervaluation. The 50.2% decline over 1 year sets the context for any new move, as investors reassess whether recent weakness has already priced in key concerns. Strong recent enthusiasm around Klaviyo’s AI marketing agents and expanded share...

Business First Bancshares (BFST) is back on investors’ radar as a series of director restricted stock unit grants and exercises, along with an upcoming second quarter 2026 earnings release, puts fresh attention on the stock. See our latest analysis for Business First Bancshares. At a share price of $30.64, Business First Bancshares has pulled back slightly in the past day but still shows firm momentum, with a 30 day share price return of 7.70% and a 3 year total shareholder return of 121.85%...